---
$id: https://graph.org.ai/products/commodity/51111733
$type: Product
source: UNSPSC
code: "51111733"
title: "Bleomycin"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bleomycin

**UNSPSC Code**: 51111733
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a bleomycin antibiotic with the molecular formula C55H84N17O21S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40S1VHN69B, more generally known as bleomycin. European Medicines Agency schedules bleomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00842MIG. The term BLEOMYCIN is an International Non-Proprietary Name or INN. Most nations schedule bleomycin under HS 29419000 and SITC 54139. As of Q4 2014, BLEOMYCIN remains the US FDA Preferred Term for this commodity. Bleomycin bears US NLM identifiers UMLS ID C0005740 and NCI Concept Code C313. SMILES: CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.

